Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc." is generating significant coverage in the Business category, with 13 articles from 13 distinct sources tracked by PULSE so far.
Outlets currently covering the story include BioPharma Dive, FirstWord Pharma, qz.com and Reuters. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 43d ago.
Quick answers
Why is "Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc." trending?
Because 13 independent news sources published 13 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (13)
- Biogen adds more immune drugs in $1B buyout of secretive startup RayThera BioPharma Dive · 45d ago
- Biogen snaps up RayThera in $1B immunology deal FirstWord Pharma · 45d ago
- Biogen acquires RayThera in deal worth up to $1 billion qz.com · 45d ago
- Biogen targets immunology growth with $1 billion RayThera deal Reuters · 45d ago
- Biogen Inc. entered into a definitive agreement to acquire RayThera, Inc. from Foresite Capital Management, LLC, OrbiMed Advisors LLC, TTM Capital and others for $1 billion. marketscreener.com · 45d ago
- Needham reiterates Buy on Biogen stock after RayThera acquisition Investing.com · 45d ago
- Needham reiterates Buy on Biogen stock after RayThera acquisition By Investing.com Investing.com Canada · 45d ago
- Biogen inks $1B RayThera buyout to bag preclinical immunology assets Fierce Biotech · 45d ago
- BIIB Stock: Biogen Strengthens Immunology Pipeline In Up To $1B RayThera Deal Stocktwits · 45d ago
- Biogen Expects to Close Deal in 3Q Moomoo · 45d ago
- Biogen (BIIB) to Acquire RayThera Inc. for Up to $1 Billion GuruFocus · 45d ago
- Biogen makes up to $1B deal for secretive anti-inflammatory biotech Endpoints News · 45d ago
- Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc. Biogen · 45d ago
Topics
Related trends
Nintendo Expands Switch 2's GameCube Library With Another Game In August
5 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
Inflammation Keeps Us Alive. It's Also Making Us Sick.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Earnings live: AstraZeneca stock rises to kick off a busy earnings week
AstraZeneca’s earnings beat lifts its stock as oncology sales buoy growth and offset a rare drug miss.
Argenx to Buy Forte Biosciences for $2.2 Billion
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
An HIV vaccine is within reach thanks to mRNA
Advancements in mRNA technology have brought the development of an HIV vaccine closer to reality through new neutralizing antibody responses.
Google Expands in Miami After Its Billionaire Founders Buy Homes
Google is quadrupling its office footprint in Miami as co-founders Larry Page and Sergey Brin relocate to South Florida.